A Phase 2 Study of Ipatasertib in Combination with Pembrolizumab for First-Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2024)